Research News and Research

RSS

Endo and Orion enter oncology R&D collaboration

Endo Pharmaceuticals announced today that it has entered into a collaboration agreement with European-based Orion Corporation for the discovery, development and commercialization of assets in Oncology.

28 Jan 2011

Majority of Americans favor foreign aid cuts, Poll finds

A USA Today/Gallup poll released on Wednesday found that a majority of Americans oppose spending cuts when asked about specific programs, except for foreign aid, The Hill's blog, "Briefing Room," reports (Fabian, 1/26).

28 Jan 2011

Tibotec grants multiple non-exclusive licenses to generic manufacturers for rilpivirine hydrochloride

Tibotec Pharmaceuticals today announced that it has granted multiple non-exclusive licenses to generic manufacturers including Hetero Drugs Limited, Matrix Laboratories Limited (a Mylan company) of India and Aspen Pharmacare of South Africa to manufacture, market and distribute the investigational non-nucleoside reverse transcriptase inhibitor rilpivirine hydrochloride (TMC278), pending its approval for use with other antiretroviral agents in the treatment of treatment-naive HIV-1 infected adults.

28 Jan 2011

New research: Retired NFL players more likely to misuse painkillers

Retired NFL players use painkillers at a much higher rate than the rest of us, according to new research conducted by investigators at Washington University School of Medicine in St. Louis.

28 Jan 2011

Hand-held PDA devices for recording daily symptoms help fibromyalgia patients: Study

Hand-held PDA devices for recording daily symptoms are helping fibromyalgia patients and their doctors better understand links between pain, emotional distress and fatigue in this complex pain disorder, according to research reported in The Journal of Pain, the peer review publications of the American Pain Society.

28 Jan 2011

Matrix enters licensing agreement with Tibotec for generic Rilpivirine Hydrochloride

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has signed an agreement with Tibotec Pharmaceuticals for a non-exclusive license to manufacture, market and distribute a generic version of the non-nucleoside reverse transcriptase inhibitor Rilpivirine Hydrochloride (TMC278), pending its regulatory approval for the treatment of treatment-naive HIV-1-infected adults.

28 Jan 2011

Viewpoints: Is Obama abandoning his health victory?

Did Obama say enough about health care reform last night? I suppose I'm one of the very few people who would even ask that question. Most Americans would probably think, "More health care? Lord no." And I think Obama and his speechwriters sensed as much. Although his defense of the Affordable Care Act was clear -- he's not going to sign a bill repealing the law -- it was also short. That portion of the speech was just two brief paragraphs, by my count (Jonathan Cohn, 1/26).

28 Jan 2011

McGill, GSK enter collaborative research agreement on cystic fibrosis

McGill University and GlaxoSmithKline plc have signed a collaboration agreement to develop a potential breakthrough approach to treat cystic fibrosis, a fatal genetic disease. The trans-Atlantic effort between researchers from McGill's Faculty of Medicine and their GSK collaborators in the UK, will focus on developing molecules that could treat the disease by correcting the dysfunction caused by the mutated gene.

28 Jan 2011

HIV causes specific subset of CD4+ T-cells to age rapidly: Study

In the early years of the AIDS epidemic, being infected with the virus that causes the disease was considered a virtual death sentence. But with the development of antiretroviral therapy, many with HIV are now living much longer. In fact, it is estimated that by 2015, about half of all HIV-positive individuals will be older than 50.

28 Jan 2011

White House renominates Berwick as Medicare chief

Six months after installing Dr. Don Berwick to direct the Center of Medicare & Medicaid Services with a recess appointment, the Obama administration has renominated him.

28 Jan 2011

Magnetic nanoparticles for ovarian cancer treatment

A paper published in the January issue of the journal Nanomedicine could provide the foundation for a new ovarian cancer treatment option - one that would use an outside-the-body filtration device to remove a large portion of the free-floating cancer cells that often create secondary tumors.

28 Jan 2011

Reuters examines how Russia's 'drug problem' has 'become an AIDS problem'

Reuters, in a piece exploring the issue of heroin use in Russia describes how the country's "drug problem has now become an AIDS problem."

28 Jan 2011

Opinions: Global poverty; Global Fund corruption; Tackling poverty, environmental issues

Ahead of the World Economic Forum in Davos, Switzerland, Laurence Chandy and Geoffrey Gert, both of the Brookings Institution's Global Economy and Development program, reflect on "Poverty's Success Story," a Washington Post opinion piece. They note that the last time the World Bank issued global poverty statistics (the number of people in the world living on less than $1.25 each day) was 2005.

28 Jan 2011

Research News and Research

Endo and Orion enter oncology R&D collaboration

Majority of Americans favor foreign aid cuts, Poll finds

Tibotec grants multiple non-exclusive licenses to generic manufacturers for rilpivirine hydrochloride

New research: Retired NFL players more likely to misuse painkillers

Hand-held PDA devices for recording daily symptoms help fibromyalgia patients: Study

Matrix enters licensing agreement with Tibotec for generic Rilpivirine Hydrochloride

Viewpoints: Is Obama abandoning his health victory?

McGill, GSK enter collaborative research agreement on cystic fibrosis

HIV causes specific subset of CD4+ T-cells to age rapidly: Study

White House renominates Berwick as Medicare chief

Magnetic nanoparticles for ovarian cancer treatment

Reuters examines how Russia's 'drug problem' has 'become an AIDS problem'

Opinions: Global poverty; Global Fund corruption; Tackling poverty, environmental issues

Discovery of aldose reductase enzyme can result in new therapies for asthma and COPD

Scientist identifies polymorphism that raises risk of poor outcomes in preterm infants

Placental colonization by bacteria could lead to preterm birth and other developmental problems

Study aims to determine risk of dementia, cognitive decline in middle-aged people

States step up legislative, legal action against federal overhaul

UMMS, Lundbeck enter research collaboration to develop targeted therapy for HD

Tobacco smoke exposure still a major cause for asthma attacks in kids: National Poll

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest Life Science News